Evaluating computational approaches for comparison of protein expression across cancer indications
Jixin WangiD, Xiaowen Tian, Wen YuiD, Ben Pullman, John Bullen, Elaine M. HurtiD, Wenyan ZhongiD
Abstract
BackgroundThe National Cancer Institutes Clinical Proteomic Tumor Analysis Consortium (CPTAC) recently generated harmonized genomic, transcriptomic, proteomic, and clinical data for over 1,000 tumors across 10 cohorts to facilitate pan-cancer discovery research. However, protein expression comparison across CPTAC cohorts remains challenging due to non-uniform missing data and varying protein expression distribution patterns across tumor types. Here, we present our efforts to evaluate various missing data handling and normalization strategies to create a normalized pan-cancer protein expression dataset. ResultsFirst, we developed a novel algorithm to select robustly expressed proteins in tumors within any CPTAC cohort. Second, we applied a cohort hybrid imputation approach to protein abundance values from FragPipe within each cohort based on protein expression distribution patterns. Third, we calculated intensity-based absolute quantification using protein abundance values and applied both global and smooth quantile normalization methods. Our results indicate that global quantile normalization ensured identical distribution across cohorts for both tumor and normal tissues, while smooth quantile normalization preserved distribution differences between biological conditions. We assessed our method by comparing differential protein expression analysis results with and without normalization. Additionally, we examined the ranks of protein expression in the normalized CPTAC dataset for selected proteins with high protein-to-RNA expression correlation across CPTAC cohorts. We then compared these protein expression ranks with their RNA expression ranks across corresponding cohorts in The Cancer Genome Atlas (TCGA). Differential protein expression analysis revealed a high level of agreement in the fold change of tumor versus normal tissue within cohorts before and after normalization. Furthermore, our results indicate that global quantile normalization resulted in the highest cohort rank correlation between CPTAC and TCGA for selected proteins. ConclusionsIn summary, our thorough analysis demonstrates that global quantile normalization surpasses both smooth quantile normalization and no normalization, as evidenced by its higher rank correlation across cancer cohorts between CPTAC and TCGA for selected proteins. The findings suggest that combining cohort hybrid imputation with global quantile normalization is an effective method for creating a normalized CPTAC pan-cancer protein dataset, which can facilitate the study of protein expression across different cancer types.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pan-cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics
Jixin Wang, Wen Yu, … Wenyan Zhong·Molecular & Cellular ProteomicsPeer-reviewed·Jul 28, 2023
- RPPA survey of cancer hotspot panel proteins and cell markers in matched tumor-normal human breast and kidney samples reveals a weak correlation between proteins expression and public transcriptome repositories
K. Paal, C. Konrad, … C. Chinopoulos·bioRxiv·Nov 9, 2023
- Simplified and unified access to cancer proteogenomic data
Caleb M. Lindgren, David W. Adams, … Samuel Payne·Journal of Proteome ResearchPeer-reviewed·Feb 9, 2021
- RoDiCE: Robust differential protein co-expression analysis for cancer complexome
Yusuke Matsui, Yuichi Abe, … Satoru Miyano·BioinformaticsPeer-reviewed·Sep 8, 2021
- Towards routine proteome profiling of FFPE tissue: Insights from a 1,200 case pan-cancer study
Johanna Tüshaus, Stephan Eckert, … Bernhard Küster·The EMBO JournalPeer-reviewed·Nov 18, 2024
- A Novel Algorithm for the Harmonization of Pan-cancer Proteomics
Nitzan Simchi, Ofer Givton, … Kirill Pevzner·bioRxiv·Mar 17, 2025